🤖 Automation and AI’s growing role are key highlights. They anticipate innovations in cell therapy and upcoming trends at the BPI meeting.
🤝 Networking opportunities at BPI also excite them, shaping a dynamic future for bioprocessing.
🔗 For more, check out the full interview!
Introduction:
The article discusses insights shared by experts on the current state of bioprocessing during an episode of the science talk show GEN Live. Co-hosted by John Sterling, the discussion features Susan Abu-Absi, PhD, and Stephen Sofen, PhD, who delve into the challenges and innovations shaping the bio-manufacturing landscape, including automation, artificial intelligence (AI), and cell and gene therapy advancements.
- The experts identify significant challenges in bioprocessing, particularly in cell and gene therapy manufacturing, and the role of contract development and manufacturing organizations (CDMOs) in this context.
- The discussion highlights the increasing importance of automation and AI in transforming bioprocessing practices and improving efficiency.
- Abu-Absi emphasizes the value of networking at industry conferences like the Bioprocess International (BPI) meeting, which combines strategic discussions with technical insights.
- Sofen raises concerns about CDMOs managing early-stage programs and their need for investment in advancing technology within tight margins.
- Both experts predict that standardization and novel technologies could greatly enhance the future of bioprocessing, with AI expected to play a pivotal role.
Conclusion:
The dialogue between the experts underscores the dynamic evolution of bioprocessing, driven by technological advancements and strategic collaborations. The upcoming BPI meeting is anticipated to catalyze further discourse on these innovations and the evolving role of CDMOs, setting the stage for future developments that may redefine the bio-manufacturing landscape.
